Why Shares of Solazyme Plunged


Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of Solazyme fell as much as 20% today after it agreed to dissolve a promising joint venture.

So what: Solazyme and Roquette, a starch and starch-derivatives company, agreed to dissolve a joint venture formed in 2010 to create alternative foods from microalgae. The companies couldn't decide on a manufacturing and marketing strategy so they decided to go their separate ways.

Now what: Instead of going forward with Roquette, Solazyme said it will accelerate commercialization of its own food ingredients, so this could result in earlier revenue than the joint venture would've provided. But, without the backing of a major food player, the company faces more risks. Until Solazyme can prove that it can commercialize products and generate significant revenue, I'm staying away. A $670 million market cap is pricing in a lot of success for a company with just $6.7 million in revenue last quarter.

Interested in more info on Solazyme? Add it to your watchlist by clicking here.

The article Why Shares of Solazyme Plunged originally appeared on Fool.com.

Fool contributor Travis Hoium has no position in any stocks mentioned. The Motley Fool owns shares of Solazyme. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.